Cero Therapeutics Holding
CERO • NASDAQ
Cero Therapeutics Holding is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher Ehrlich, with a market cap of $177.4K.
CEOChristopher Ehrlich
Next Earnings
Upcoming earnings announcement for Cero Therapeutics Holding
Date
Thursday, May 14, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.00
Earnings History
Past 7 earnings reports for Cero Therapeutics Holding
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Q3 2025 | -$9.10Est: -$4.35 | -109.2% | - | — |  10-Q |
| Aug 22, 2025 | Q2 2025 | -$61.71Est: -$6.21 | -893.7% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$1.59 | — | - | — | 10-Q |
| Apr 15, 2025 | Q4 2024 | — | — | — | — | 10-K/A |
| Nov 19, 2024 | Q3 2024 | -$9.00 | — | - | — | 10-Q/A |
| Aug 14, 2024 | Q2 2024 | -$15.00 | — | - | — | 10-Q |
| May 17, 2024 | Q1 2024 | -$18.00 | — | - | — | 10-Q |